End-To-End Services from a Single Facility
Our Pessano, Italy site is a 220,000 sq ft (20.4k sq m) facility providing clinical and commercial scale manufacturing—including clinical batch manufacturing and organic solvent capabilities—for the US, European, and Japanese markets.
The facility’s expanded R&D capabilities provide customizable, flexible systems that expedite formulation & process development services. These expanded services allow for both clinical & commercial manufacturing at the Pessano facility, streamlining development timelines for our global customers.
Pessano Site Overview
- 24/5 Work Schedule
- Clinical and Commercial scale manufacturing
- Manufacturing of clinical batches
- Organic solvent capabilities
- Serves US, European, and Japanese markets
- Key Capabilities:
- Granules
- Plain tablets
- Film- or sugar- coated tablets
- Hard-gelatin or HPMC capsules
- Microcaps®
- Microtabs
- MMTS™ Minitabs
- Diffucaps®
- Extruded – spheronized
- Controlled substances (DPR 309/90)
- Safety standard obtained (ISO 45001)
Faster Development Timelines With Reduced API
- Non-GMP Small Scale Laboratory
- Provides additional early-stage non-GMP development capacity
- Produces smaller batches using less active
pharmaceutical ingredients - Allows projects to initiate immediately
- Reduces development timelines
- Mirrors Adare’s pilot & production capabilities
- Integrated R&D validated through to commercial manufacturing
- Full-service capabilities for even the most complex product creation
- Flexible business model customized to fit your program
- In-house regulatory affairs team with proven global track record
– Microcaps® (organic or aqueous) – Granules, Diffucaps® (fluid-bed coating), Extruded-Spheronized bulk – Tablets, capsules
– Diffucaps® (pan coating) – MMTSTM Minitabs, Microtabs,Tablets containing enzymes (controlled area)
